The Task of Desferrioxamine and Iron in the Immune Interplay between mononuclears and Colon Cancer Cells
Open Access
- 1 January 2017
- journal article
- Published by Ommega Online Publishers in Journal of Immunology and Serum Biology
- Vol. 3 (1), 1-6
- https://doi.org/10.15436/2471-5891.17.1277
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Pharmacological Targeting of the Hepcidin/Ferroportin AxisFrontiers in Pharmacology, 2016
- IRON, INFLAMMATION AND INVASION OF CANCER CELLSMedicine and Pharmacy Reports, 2015
- Iron homeostasis in host defence and inflammationNature Reviews Immunology, 2015
- Disordered hepcidin–ferroportin signaling promotes breast cancer growthCellular Signalling, 2014
- Iron metabolism in breast cancer: knowledge and futureAnnales de biologie clinique, 2012
- Hepcidin and iron regulation, 10 years laterBlood, 2011
- The role of iron in tumour cell proliferationClinical and Translational Oncology, 2011
- An update on iron physiologyWorld Journal of Gastroenterology, 2009
- Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza AEuropean Journal of Clinical Investigation, 2002
- Breast Carcinoma and the Role of Iron MetabolismAnnals of the New York Academy of Sciences, 1993